A Ketamine Infusion Improved Sleep in These Patients
Depression and anxiety improved together in the 24 hours after a ketamine infusion. Sleep improved too, and it moved independently of both. That is the finding in a study published this week in Translational Psychiatry. It has a practical consequence for any clinic that tracks one scale and calls it the result.
What a clinic measures today becomes what it can prove in two years. HealingMaps’ GPO, the first built for the ketamine industry, gets member clinics 40 percent or more off medical supplies, 15 to 20 percent off malpractice and liability premiums, discounted LegitScript certification, and 20 to 30 percent off HIPAA compliant payment processing. Joining is free with no obligation. See what your clinic qualifies for →
| Key Takeaway | Detail |
|---|---|
| The study | 71 patients with treatment-resistant depression, assessed at baseline and 24 hours |
| The treatment | A single intravenous ketamine infusion at 0.5 mg/kg |
| What improved | Depression, anxiety and insomnia all fell significantly |
| What moved together | Change in anxiety tracked change in depression closely |
| What moved alone | Change in insomnia was not tied to change in depression or anxiety |
| The limit | A before and after comparison at 24 hours, with no control contrast in this analysis |
What the Researchers Measured
The team came from the National Institute of Mental Health and collaborating universities. They studied 71 patients with treatment-resistant depression.
Each patient was assessed at baseline and again 24 hours after a single infusion of 0.5 mg/kg ketamine.
They used the MADRS for depression, the HAM-A for anxiety, and insomnia items drawn from the Hamilton Depression Rating Scale. A subset also had sleep studies.
All Three Got Better
Depression scores fell, with a coefficient of 11.72 points on the MADRS. Anxiety fell by 7.87 points on the HAM-A. Insomnia fell as well.
Every one of those changes was statistically significant at p below 0.001. Nothing here is subtle.
Patients who started with the worst insomnia saw the largest absolute improvement in it.
The Interesting Part Is What Did Not Travel Together
Change in anxiety tracked change in depression closely, at a correlation of 0.61. When one improved, so did the other.
Insomnia behaved differently. Its change was not significantly associated with change in depression or change in anxiety.
Here is what that means in plain terms. A patient could post a large sleep improvement alongside a modest mood improvement, or the reverse. If sleep were simply riding along behind mood, the two would have risen and fallen together.
So the sleep gain does not look like a byproduct of feeling less depressed. That is a different claim from saying ketamine caused it. Everyone in this study received ketamine, with no comparison group, so the design cannot separate the drug from time, setting or expectation.
The Sleep Data Beneath It
Exploratory sleep studies pointed the same way. Patients showed more total sleep time, more slow-wave sleep and better sleep efficiency.
They also fell asleep faster. The authors label this analysis exploratory, so treat it as supporting detail rather than a headline.
What a Clinic Should Do With This
Most practices track one depression scale. If sleep improves on a separate track, a PHQ-9 alone will not capture it.
Adding a brief sleep measure at intake and follow up costs almost nothing. It can surface a benefit a patient feels but a questionnaire never records.
It also matters for the conversation with patients. Someone whose mood score barely moves may still be sleeping through the night, and that is worth naming.
We made the same argument about measurement in our piece on outcomes as a moat. Our look at how instruments shape findings covers the other half.
How Much Weight to Give It
This analysis compares patients to themselves before and after. It does not contrast them against a placebo group, so expectancy cannot be separated out.
Insomnia was captured with items from a depression scale rather than a dedicated sleep instrument. That is a blunt tool for a specific question.
The window is also short. Twenty four hours tells you about the first day, not about week six.
One disclosure belongs here. The senior author is a co-inventor on patents covering ketamine for depression, which the paper states directly.
Where It Fits
The 24 hour mark keeps showing up in ketamine research. We covered the brain imaging version in two studies pointing at the day after the infusion.
Other recent work has looked at who responds and why, including dissociation and response and a controlled trial in bipolar depression.
Taken together, they describe a treatment whose effects are not one single thing moving in one direction.
The Bottom Line
Ketamine improved mood, anxiety and sleep in this group, and the sleep change did not follow the mood change.
A clinic that measures only depression will report less than it delivers. That is a cheap problem to fix.
Patients looking for supervised care can start with our directory of verified ketamine clinics.
This article is for informational purposes and is not medical advice. The study described measured symptoms 24 hours after a single infusion and does not establish longer term effects.
